These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15565459)

  • 1. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
    Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
    Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
    Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
    Narita D; Seclaman E; Ursoniu S; Anghel A
    Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM-17 expression in breast cancer correlates with variables of tumor progression.
    McGowan PM; Ryan BM; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Clin Cancer Res; 2007 Apr; 13(8):2335-43. PubMed ID: 17438092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
    Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
    Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers.
    Charrier L; Yan Y; Driss A; Laboisse CL; Sitaraman SV; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G346-53. PubMed ID: 15358598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of ADAM (a disintegrin and metalloproteinase) genes between human first trimester villous and extravillous trophoblast cells.
    Takahashi H; Yuge K; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Suzuki M; Takizawa T
    J Nippon Med Sch; 2014; 81(3):122-9. PubMed ID: 24998958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
    Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
    Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS.
    Kärkkäinen I; Rybnikova E; Pelto-Huikko M; Huovila AP
    Mol Cell Neurosci; 2000 Jun; 15(6):547-60. PubMed ID: 10860581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.
    Blanchot-Jossic F; Jarry A; Masson D; Bach-Ngohou K; Paineau J; Denis MG; Laboisse CL; Mosnier JF
    J Pathol; 2005 Oct; 207(2):156-63. PubMed ID: 16041691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone.
    McCulloch DR; Harvey M; Herington AC
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):11-21. PubMed ID: 11000516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of ADAM12 in human bladder cancer.
    Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
    Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ADAM-9 mRNA and protein in human breast cancer.
    O'Shea C; McKie N; Buggy Y; Duggan C; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Int J Cancer; 2003 Jul; 105(6):754-61. PubMed ID: 12767059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
    Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
    Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
    Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
    J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.
    McCulloch DR; Akl P; Samaratunga H; Herington AC; Odorico DM
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):314-23. PubMed ID: 14734484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria.
    Arndt M; Lendeckel U; Röcken C; Nepple K; Wolke C; Spiess A; Huth C; Ansorge S; Klein HU; Goette A
    Circulation; 2002 Feb; 105(6):720-5. PubMed ID: 11839628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.